Progression of hearing loss in neurofibromatosis type 2 according to genetic severity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progression of hearing loss in neurofibromatosis type 2 according to genetic severity

Published:2018-11-19 Issue:4 Volume:129 Page:974-980
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Emmanouil Beatrice¹^ORCID,Houston Rory²,May Anne¹,Ramsden James D.²,Hanemann C. Oliver³,Halliday Dorothy¹⁴,Parry Allyson¹,Mackeith Samuel¹²

Affiliation:

1. Oxford NF2 Unit, Neurosciences Oxford United Kingdom

2. Department of ENTOxford University Hospitals NHS Foundation Trust Oxford United Kingdom

3. Department of NeurologyDerriford Hospital Plymouth United Kingdom

4. Oxford Centre for Genomic MedicineOxford University Hospitals NHS Foundation Trust Oxford United Kingdom

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.27586

Reference41 articles.

1. Neurofibromatosis type 2 (NF2): A clinical and molecular review

2. Hearing optimisation in neurofibromatosis type 2: A systematic review

3. Psychosocial effects of neurofibromatosis type 2 (Part 1): General effects

4. Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2

5. Quality of Life (QoL) Assessment in Patients with Neurofibromatosis Type 2 (NF2)

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas;Hearing Research;2024-06

2. Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2‐Related Schwannomatosis;The Laryngoscope;2023-11-20

3. Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma;Cureus;2023-09-29

4. Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro;Molecular Therapy - Nucleic Acids;2022-12

5. Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience;Neurosurgical Focus;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3